Levetiracetam G.L.

Levetiracetam, the active ingredient in Levetiracetam G.L., is an anticonvulsant presented as an oral formulation for oral use. It belongs to the antiepileptic drug class and is indicated for the treatment of several seizure types in patients with epilepsy, helping to reduce neuronal excitability.

GNH USA supplies Levetiracetam G.L. as a licensed, GDP‑compliant international pharmaceutical supplier, providing the product to hospitals, pharmacies and clinics worldwide, sourced from EU‑approved manufacturers and ensuring quality and regulatory compliance.

Levetiracetam is an antiepileptic medication used to control various seizure disorders.

Partial-onset seizures: reduces the frequency of focal seizure episodes in patients with epilepsy. Generalized tonic-clonic seizures: helps control convulsive episodes in generalized epilepsy. Myoclonic seizures: decreases the occurrence of rapid muscle jerks in appropriate patients.

Levetiracetam may cause a range of adverse reactions, which vary in frequency and severity.

Common Side Effects: - Dizziness - Fatigue - Headache - Nausea - Irritability - Somnolence

Serious or Rare Side Effects: - Severe allergic reactions such as anaphylaxis - Mood alterations including depression or suicidal thoughts - Skin reactions such as Stevens‑Johnson syndrome or toxic epidermal necrolysis - Hematologic abnormalities like leukopenia - Hepatic dysfunction

Before initiating therapy, clinicians should consider several safety aspects. - Renal impairment: adjust dose based on renal function. - Concomitant CNS depressants: monitor for enhanced sedation. - History of psychiatric disorders: observe for mood changes. - Pregnancy: discuss potential risks with a healthcare provider. - Store at ambient temperature: keep in the original container, protect from moisture and light.

Levetiracetam can interact with other medicines, requiring careful management.

Major Interactions (Avoid): - Carbamazepine: may reduce levetiracetam plasma concentrations. - Phenobarbital: may decrease levetiracetam efficacy. - Phenytoin: may lower levetiracetam levels.

Moderate Interactions (Monitor Closely): - Alcohol: can increase central nervous system depression. - Opioids: may enhance sedation and respiratory depression. - Other antiepileptics (e.g., valproate): monitor therapeutic response and side‑effect profile.